Events
Wearables Webinar Series, Part 3: Product Liability and IP Strategies for Wearables
November 4, 2025
| Webinar
| Duane Morris LLP
Duane Morris will present a webinar, Wearables Webinar Series, Part 3: Product Liability and IP Strategies for Wearables, on Tuesday, November 4, 2025 | 12:00 p.m. to 12:30 p.m. Eastern.
0.5 hours of CLE credit pending
About the Program
As wearables continue to reshape industries—from healthcare to consumer tech—their legal implications are evolving just as rapidly. This session brings together three Duane Morris attorneys to unpack the challenges and opportunities companies face in this dynamic space. In the final installment of our series on wearable devices, Duane Morris partners will go over:
- Product Liability and Wearables - Sean Burke
- The wearable industry challenges traditional legal frameworks, creating uncertainty for companies navigating potential exposure to product liability litigation. Sean Burke will highlight key issues, emerging trends and strategies to mitigate risk.
- FDA Oversight of AI and Machine Learning in Medical Devices - Agatha Liu
- Agatha Liu, Ph.D., will cover how wearables with diagnostic, monitoring or therapeutic claims fall under the FDA’s software as a medical device framework, including predetermined change control plans, good machine learning practices and real-world performance monitoring of adaptive algorithms.
- Intellectual Property Strategies for Wearables - Jason Luo
- Jason Luo, Ph.D., will discuss patenting trends and strategies, including timing, jurisdictions and portfolio development, patentability requirements for software and AI, and post-allowance strategies and global due diligence.
Presenters
About the Webinar Series
Over a series of three mini-webinars, Duane Morris attorneys will offer high-level guidance on current FDA regulations, cybersecurity and data privacy, and product liability and IP strategies for wearables.
About the Duane Morris Life Sciences and Medical Technologies Group
As biotech, biopharma and pharma companies develop new therapeutics, aligning legal strategies with development and commercialization goals throughout the extensive process of funding, R&D, clinical trials and market entry is imperative to a company’s strategy, success and growth. We assist clients in developing and implementing strategies to protect and expand their pipeline and maximize the benefit of their products to their target patient population.
About Duane Morris
Duane Morris LLP, a law firm with more than 900 attorneys in offices across the United States and internationally, is asked by a broad array of clients to provide innovative solutions to today’s legal and business challenges. Duane Morris has been recognized by BTI Consulting as both a client service leader and a highly recommended law firm.